Dr Randeep Kaur Brar, MD | |
10423 Old Placerville Rd, Sacramento, CA 95827-2540 | |
(916) 569-8600 | |
Not Available |
Full Name | Dr Randeep Kaur Brar |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 10423 Old Placerville Rd, Sacramento, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033490438 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | A149179 (California) | Primary |
Entity Name | Wellspace Health |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124112933 PECOS PAC ID: 8426157975 Enrollment ID: O20070623000117 |
News Archive
CVRx, Inc., a privately held medical device company, announced today that it has received Humanitarian Device Exemption (HDE) approval from the U.S. Food and Drug Administration for its Barostim neo legacy device.
Illumina, Inc. today announced the pricing of $800 million principal amount of 0.25% Convertible Senior Notes due 2016 through offerings to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
Progesterone, a female hormone that can be used as a therapy for endometrial cancer, eliminates tumor cells indirectly by binding to its receptor in stromal or connective tissue cells residing in the tumor microenvironment, according to a study from the G.O. Discovery Lab team and collaborators at UCLA.
Cerapedics, a privately-held orthobiologics company, announced today the U.S. Food and Drug Administration (FDA) has approved the company's Premarket Approval (PMA) application for i-FACTOR™ Peptide Enhanced Bone Graft for use in anterior cervical discectomy and fusion (ACDF) procedures in patients with degenerative cervical disc disease. i-FACTOR bone graft is the first bone graft to be approved for use in the cervical spine and only the second PMA-approved bone graft in the spine.
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Randeep Kaur Brar, MD 2414 Sisley Ct, Davis, CA 95618-7622 Ph: () - | Dr Randeep Kaur Brar, MD 10423 Old Placerville Rd, Sacramento, CA 95827-2540 Ph: (916) 569-8600 |
News Archive
CVRx, Inc., a privately held medical device company, announced today that it has received Humanitarian Device Exemption (HDE) approval from the U.S. Food and Drug Administration for its Barostim neo legacy device.
Illumina, Inc. today announced the pricing of $800 million principal amount of 0.25% Convertible Senior Notes due 2016 through offerings to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
Progesterone, a female hormone that can be used as a therapy for endometrial cancer, eliminates tumor cells indirectly by binding to its receptor in stromal or connective tissue cells residing in the tumor microenvironment, according to a study from the G.O. Discovery Lab team and collaborators at UCLA.
Cerapedics, a privately-held orthobiologics company, announced today the U.S. Food and Drug Administration (FDA) has approved the company's Premarket Approval (PMA) application for i-FACTOR™ Peptide Enhanced Bone Graft for use in anterior cervical discectomy and fusion (ACDF) procedures in patients with degenerative cervical disc disease. i-FACTOR bone graft is the first bone graft to be approved for use in the cervical spine and only the second PMA-approved bone graft in the spine.
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.
› Verified 4 days ago
Lena Claire Van Der List, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 2516 Stockton Blvd, Sacramento, CA 95817 Phone: 916-734-2428 | |
Dr. Mary Beth J Steinfeld, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2825 50th St, Uc Davis Department Of Pediatrics, Sacramento, CA 95817 Phone: 916-703-0271 Fax: 916-703-0243 | |
Lindalee G Huston, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5301 F St, #220, Sacramento, CA 95819 Phone: 916-455-8000 Fax: 916-733-6088 | |
Alison My Lam, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2516 Stockton Blvd, Sacramento, CA 95817 Phone: 916-734-3665 | |
Marcela Lau, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2025 Morse Ave, Sacramento, CA 95825 Phone: 916-973-5000 | |
Donald Morley Null, Jr., MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2315 Stockton Blvd, Nicu, Sacramento, CA 95817 Phone: 916-703-3050 Fax: 916-703-3055 | |
Dr. Elizabeth Partridge, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2516 Stockton Blvd, Sacramento, CA 95817 Phone: 510-428-4337 |